Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780 J Infect Dis | © 2005 by the Infectious Diseases Society of America From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780 J Infect Dis | © 2005 by the Infectious Diseases Society of America From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780 J Infect Dis | © 2005 by the Infectious Diseases Society of America From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780 J Infect Dis | © 2005 by the Infectious Diseases Society of America From: rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers J Infect Dis. 2005;191(5):710-718. doi:10.1086/427780 J Infect Dis | © 2005 by the Infectious Diseases Society of America